| Otten, Hans-Martin |
SIRIUS, NCT05375708: Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites |
|
|
| Not yet recruiting | 2 | 93 | Europe | Stereotactic body radiation therapy (SBRT), Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.) | UMC Utrecht | Metastatic Colorectal Cancer, Oligometastatic Disease | 06/28 | 06/28 | | |
NCT05229471: Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study |
|
|
| Recruiting | N/A | 220 | Europe | | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), G. d'Annunzio University | Cancer, Venous Thromboembolism, Recurrence | 12/23 | 12/24 | | |
| Hamer, BJB |
PINNACLE I, NCT05828173: A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter |
|
|
| Active, not recruiting | N/A | 60 | Europe | LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter (LithiX Coronary HCIVLC; LithiX) | Elixir Medical Corporation | Coronary Artery Disease | 04/24 | 09/24 | | |
| Consten, ECJ |
NCT02301286: A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients |
|
|
| Active, not recruiting | 3 | 770 | Europe | Acetylsalicylic acid, Aspirin, Placebo Acetylsalicylic acid, Placebo | Leiden University, Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS), Dutch Colorectal Cancer Group, Stichting Geriatrische Oncologie Nederland (GeriOnNe), Fonds NutsOhra, Innovatiefonds Zorgverzekeraars | Colon Cancer, Adjuvant Therapy | 12/27 | 12/27 | | |
| Intven, Martijn |
SIRIUS, NCT05375708: Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites |
|
|
| Not yet recruiting | 2 | 93 | Europe | Stereotactic body radiation therapy (SBRT), Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.) | UMC Utrecht | Metastatic Colorectal Cancer, Oligometastatic Disease | 06/28 | 06/28 | | |
NCT03426397: "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer |
|
|
| Recruiting | N/A | 220 | Europe | | The Netherlands Cancer Institute, Dutch Cancer Society | Rectal Neoplasms | 06/21 | 06/26 | | |
| Recruiting | N/A | 98 | Europe | stereotactic ablative radiotherapy | VU University Medical Center, UMC Utrecht, Erasmus Medical Center, Dutch Cancer Society, Viewray Inc. | Pancreatic Cancer Non-resectable | 03/24 | 06/24 | | |
| Jong, Joyce van Dodewaard - de |
ANZadapt, NCT05393791: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC |
|
|
| Recruiting | 2 | 168 | Europe, RoW | Patient-specific adaptive therapy, Abiraterone acetate, Zytiga, Enzalutamide, Xtandi | Leiden University Medical Center, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Anticancer Fund, Belgium | Prostatic Neoplasms, Castration-Resistant | 11/27 | 11/27 | | |
